These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38281467)

  • 21. Updating the core domains set in Systemic Lupus Erythematosus: Work planned by the Systemic Lupus Erythematosus OMERACT working group.
    Nielsen W; Strand V; Simon LS; Thumboo J; Mosca M; Aringer M; Morand EF; Bruce I; Touma Z
    Lupus; 2023 Apr; 32(4):586-588. PubMed ID: 36912276
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.
    Helliwell T; Brouwer E; Pease CT; Hughes R; Hill CL; Neill LM; Halls S; Simon LS; Mallen CD; Boers M; Kirwan JR; Mackie SL
    J Rheumatol; 2016 Jan; 43(1):182-6. PubMed ID: 26568595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group.
    Balay-Dustrude E; Christensen R; Consolaro A; Ingrid Goh Y; Gottlieb BS; Horgan B; Horonjeff J; Maxwell LJ; Munro J; Pan N; Schultz G; Swart JF; Toupin-April K; Morgan EM
    Semin Arthritis Rheum; 2024 Feb; 64():152340. PubMed ID: 38071831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.
    Toupin-April K; Décary S; de Wit M; Meara A; Barton JL; Fraenkel L; Li LC; Brooks P; Shea B; Stacey D; Légaré F; Lydiatt A; Hofstetter C; Proulx L; Christensen R; Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Guillemin F; Beaton D; El-Miedany Y; Mittoo S; Westrich Robertson T; Bartlett SJ; Singh JA; Mannion M; Nasef SI; de Souza S; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Carrott D; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Umaefulam V; Monti S; Melburn C; Abaza N; Schultz K; Stones S; Kiwalkar S; Srinivasalu H; Constien D; King LK; Tugwell P
    Semin Arthritis Rheum; 2021 Jun; 51(3):593-600. PubMed ID: 33892937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains.
    Smolen JS; Strand V; Cardiel M; Edworthy S; Furst D; Gladman D; Gordon C; Isenberg DA; Klippel JH; Petri M; Simon L; Tugwell P; Wolfe F
    J Rheumatol; 1999 Feb; 26(2):504-7. PubMed ID: 9972996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of the American College of Rheumatology Patient-Reported Outcome Quality Measures for Systemic Lupus Erythematosus.
    Katz PP; Barber CEH; Duarte-García A; Garg S; Machua W; Rodgers W; Santiago-Casas Y; Suter L; Bartels CM; Yazdany J
    Arthritis Care Res (Hoboken); 2024 Jun; 76(6):777-787. PubMed ID: 38225171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.
    Nielsen SM; Tugwell P; de Wit MPT; Boers M; Beaton DE; Woodworth TG; Escorpizo R; Shea B; Toupin-April K; Guillemin F; Strand V; Singh JA; Kloppenburg M; Furst DE; Wells GA; Smolen JS; Veselý R; Boonen A; Storgaard H; Voshaar M; March L; Christensen R;
    J Rheumatol; 2019 Sep; 46(9):1159-1163. PubMed ID: 30647174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies.
    Kloppenburg M; Bøyesen P; Visser AW; Haugen IK; Boers M; Boonen A; Conaghan PG; Hawker GA; Kvien TK; Landewé R; Uhlig T; Smeets W; Greibrokk E; van der Heijde DM
    J Rheumatol; 2015 Nov; 42(11):2190-7. PubMed ID: 26136489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
    Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
    Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients.
    Corzo P; Salman-Monte TC; Torrente-Segarra V; Polino L; Mojal S; Carbonell-Abelló J
    Lupus; 2017 Jun; 26(7):729-733. PubMed ID: 27837195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need.
    Guo LN; Perez-Chada LM; Borucki R; Nambudiri VE; Werth VP; Merola JF
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34969875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
    Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
    Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
    J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative.
    Weinbrecht-Mischkewitz M; Kamal M; Asim F; Guillemin F; Goel N; Voshaar M; Boonen A; Berthelsen DB; Toupin-April K; Lopez-Olivo MA; Sloan VS; Boers M; Jones CA; van der Horst-Bruinsma I; Cashin AG; Sharma S; Leong A; Alten R; Shea B; March L; Tugwell P; Christensen R; Nielsen SM;
    Semin Arthritis Rheum; 2024 Apr; 65():152370. PubMed ID: 38290371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working group.
    King LK; Epstein J; Cross M; Buzzi M; Buttel T; Cembalo SM; Spitz E; Adams CL; Adebajo A; Bennell K; Blanco B; Courage U; Décary S; Gill M; Gill TK; Hajji R; Hinman RS; Jones A; Li LC; Mather K; Mani R; Nasef SI; Oo WM; Østerås N; Otobo TM; Ramiro S; Sharma S; April KT; Touma Z; Whittaker JL; Wluka AE; Grosskleg S; Hunter DJ; Shea B; Hawker GA; Callahan LF; March L; Guillemin F
    Semin Arthritis Rheum; 2021 Jun; 51(3):618-622. PubMed ID: 33775461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.